Gary Gelbfish, MD
Vascular Surgery · New York, NYNPI 1275508954
Payments from drug & device makers
What this record shows
This record is dominated by other: $1,928,661 of the $1,928,972 with a category attached, or 100.0%. Stryker accounts for 100.0% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2024 at $1,928,678 and has fallen 100.0% since, to $24 in 2025. Among vascular surgery clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 11 payments — averaging $175,361 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$1.9M
- Bard Peripheral Vascular, Inc.$187
- Boston Scientific$46
- Takeda Pharmaceuticals U.S.A., Inc.$24
- Medtronic$20
- Argon Medical Devices, Inc.$17
- plus $17 from 1 others
What the payments were for
- Food & beverage$3110%
- Other$1,928,661100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 2 | $1,928,661 |
| Bard Peripheral Vascular, Inc. | 4 | $187 |
| Boston Scientific | 1 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Medtronic | 1 | $20 |
| Argon Medical Devices, Inc. | 1 | $17 |
| Merck | 1 | $17 |
How this compares
$1,928,972 in reported general payments places this provider in the 95th percentile of 405 vascular surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other vascular surgery in New York
- John LantisNew York$922K
- Brian DerubertisNew York$714K
- James McKinseyNew York$616K
- Peter FariesNew York$494K
- Ajit RaoNew York$294K
- Daniel HanNew York$280K
- Todd BerlandNew York$260K
- Thomas MaldonadoNew York$249K
- Karan GargNew York$246K
- Rami TadrosNew York$218K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.